Emergency medical and fire-rescue professionals
tend to equate cyanide poisoning with accidental or intentional
ingestion. However, cyanide toxicity from smoke inhalation in a
structural or an enclosed-space fire is the most likely cause of cyanide
toxicity that EMS and fire professionals will encounter.
Hydrogen cyanide, the gaseous form of cyanide, is
generated by the combustion of nitrogen- and carbon-containing
substances, including wool, silk, cotton and paper, as well as synthetic
substances, such as plastics and other polymers. Because of our
extensive reliance on the polymer industry’s nitrogen- and
carbon-containing products, these hydrogen cyanide substrates are
ubiquitous in occupied structures. Hydrogen cyanide is likely to be
produced under burning conditions of high temperature and low oxygen,
both of which are characteristic of closed-space fires. An enclosed
space serves as a container for the toxic gases in smoke, such as
hydrogen cyanide.
Smoke inhalation-associated cyanide poisoning
manifestations vary. In victims with low inhaled-cyanide concentrations
or very recent exposure to moderate or high concentrations,
manifestations may include faintness, flushing, anxiety, excitement,
perspiration, vertigo, headache, drowsiness, tachypnea, dyspnea and
tachycardia.
In victims with moderate or high concentrations,
manifestations may include prostration, tremors, cardiac arrhythmia,
convulsions, stupor, paralysis, coma, respiratory depression,
respiratory arrest and cardiovascular collapse.
Firefighters and victims with smoke
inhalation-associated cyanide poisoning often experience cognitive
dysfunction and drowsiness that can impair the fight-or-flight response.
Treatment for hydrogen cyanide poisoning must be
administered as quickly as possible after exposure. Therefore,
presumptive diagnosis and empiric treatment prove necessary to save
lives.
Prehospital management of acute cyanide poisoning
in the smoke inhalation victim involves moving the victim from the
source of exposure (while maintaining appropriate provider respiratory
protection, SCBA), restoring or maintaining airway patency,
administering 100% oxygen via non-rebreather mask or bag-valve mask
technique, aggressive advanced airway management, including early
intubation, providing cardiopulmonary support and stabilizing vital
signs, including the use of trauma and burn management (Parkland
formula). When clinically indicated, anticonvulsants (benzodiazpines)
should be given for seizures, epinephrine and antiarrhythmics to
stabilize cardiovascular function, and sodium bicarbonate to correct
metabolic acidosis if known. Effective cyanide antidotes exist. However,
a cyanide antidote appropriate for use in smoke-inhalation victims is
not yet available in the United States.
Hydroxocobalamin, a precursor of vitamin B12, is
being investigated for possible introduction in the United States to
meet the need for an antidote that can be used safely on an empiric
basis.
For now, the best course of pre-hospital
intervention is the provision of rapid transport to a hospital ED or
burn center where definitive treatment can be delivered.
Excerpted from Smoke Inhalation & Hydrogen Cyanide
Poisoning, an editorial supplement to JEMS, Summer 2004. To download a
PDF of the complete supplement, visit